ClearPoint Neuro, Inc.
General ticker "CLPT" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $391.7M (TTM average)
ClearPoint Neuro, Inc. follows the US Stock Market performance with the rate: 9.9%.
Estimated limits based on current volatility of 4.1%: low 14.56$, high 15.81$
Factors to consider:
- Total employees count: 115 (+7.5%) as of 2024
- Top business risk factors: Customer concentration, Regulatory and compliance, Market competition, R&D failure, Capital shortage
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [8.08$, 18.44$]
- 2026-12-31 to 2027-12-31 estimated range: [6.47$, 15.40$]
Financial Metrics affecting the CLPT estimates:
- Negative: with PPE of -15.4 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -6.01 <= 0.28
- Positive: Interest expense per share per price, % of 0.60 <= 0.75
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 0.15 > -0.64
Short-term CLPT quotes
Long-term CLPT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $23.95MM | $31.39MM | $36.97MM |
| Operating Expenses | $46.40MM | $51.12MM | $61.13MM |
| Operating Income | $-22.45MM | $-19.73MM | $-24.16MM |
| Non-Operating Income | $0.36MM | $0.83MM | $-1.32MM |
| Interest Expense | $0.00MM | $0.52MM | $2.39MM |
| R&D Expense | $11.71MM | $12.39MM | $13.90MM |
| Income(Loss) | $-22.09MM | $-18.90MM | $-25.48MM |
| Taxes | $0.00MM | $0.01MM | $0.06MM |
| Net Income(Loss)* | $-22.09MM | $-18.91MM | $-25.54MM |
| Stockholders Equity | $21.17MM | $25.39MM | $28.02MM |
| Inventory | $7.91MM | $6.86MM | $8.36MM |
| Assets | $42.66MM | $39.19MM | $97.75MM |
| Operating Cash Flow | $-13.72MM | $-8.95MM | $-23.93MM |
| Capital expenditure | $0.72MM | $0.28MM | $0.52MM |
| Investing Cash Flow | $8.95MM | $-0.28MM | $0.61MM |
| Financing Cash Flow | $0.30MM | $6.19MM | $50.18MM |
| Earnings Per Share** | $-0.90 | $-0.70 | $-0.90 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.